{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:30:07Z","timestamp":1793673007261,"version":"4.5.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["15\/TIDA\/2945"],"award-info":[{"award-number":["15\/TIDA\/2945"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["16\/IA\/4584"],"award-info":[{"award-number":["16\/IA\/4584"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["R01CA198096"],"award-info":[{"award-number":["R01CA198096"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA198096"],"award-info":[{"award-number":["R01CA198096"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30CA016056"],"award-info":[{"award-number":["P30CA016056"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","award":["GOIPG\/2015\/3492"],"award-info":[{"award-number":["GOIPG\/2015\/3492"]}],"id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000704","name":"Royal Society of Chemistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004437","name":"European Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004437","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.actbio.2022.12.057","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T11:39:09Z","timestamp":1672659549000},"page":"611-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-6612","authenticated-orcid":false,"given":"Cara","family":"Moloney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8511-6683","authenticated-orcid":false,"given":"Tista Roy","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5049-4737","authenticated-orcid":false,"given":"Joseph A.","family":"Spernyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Straubinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1270-8415","authenticated-orcid":false,"given":"Dermot F.","family":"Brougham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2022.12.057_bib0001","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.actbio.2022.12.057_bib0002","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New developments in liposomal drug delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.actbio.2022.12.057_bib0003","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1002\/jps.21358","article-title":"Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development","volume":"97","author":"Drummond","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2022.12.057_bib0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.06.022","article-title":"Recent advancements in liposome technology","volume":"156","author":"Filipczak","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2022.12.057_bib0005","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acsnano.9b04266","article-title":"Integrating nanotechnology into cancer care","volume":"13","author":"Grodzinski","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2022.12.057_bib0006","first-page":"15","article-title":"Liposomes in drug delivery","volume":"45","author":"Gregoriadis","year":"1993","journal-title":"Clin., Diagnos. Ophthalmic Potential, Drugs"},{"key":"10.1016\/j.actbio.2022.12.057_bib0007","series-title":"Liposomes: From Physical Structure to Therapeutic Applications","author":"Fildes","year":"1981"},{"key":"10.1016\/j.actbio.2022.12.057_bib0008","doi-asserted-by":"crossref","first-page":"8507","DOI":"10.2147\/IJN.S183117","article-title":"Liposome delivery systems for the treatment of Alzheimer's disease","volume":"13","author":"Ross","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2022.12.057_bib0009","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of PEGylated liposomal doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.actbio.2022.12.057_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2016.353","article-title":"Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells","volume":"36","author":"Richards","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2022.12.057_bib0011","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nat"},{"key":"10.1016\/j.actbio.2022.12.057_bib0012","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/jnci\/81.19.1484","article-title":"Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times","volume":"81","author":"Gabizon","year":"1989","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/j.actbio.2022.12.057_bib0013","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.1997.15.3.987","article-title":"Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation","volume":"15","author":"Muggia","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.actbio.2022.12.057_bib0014","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2018.12.007","article-title":"NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: final overall survival analysis and characteristics of long-term survivors","volume":"108","author":"Wang-Gillam","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.actbio.2022.12.057_bib0015","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1158\/0008-5472.CAN-05-4007","article-title":"Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy","volume":"66","author":"Drummond","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2022.12.057_bib0016","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1158\/1078-0432.CCR-16-1990","article-title":"Correlation between ferumoxytol uptake in tumor lesions by MRI and response to nanoliposomal irinotecan in patients with advanced solid tumors: a pilot study","volume":"23","author":"Ramanathan","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2022.12.057_bib0017","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Sci"},{"key":"10.1016\/j.actbio.2022.12.057_bib0018","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1158\/1535-7163.MCT-15-0602","article-title":"Tumor-priming smoothened inhibitor enhances deposition and efficacy of cytotoxic nanoparticles in a pancreatic cancer model","volume":"15","author":"Chaudhuri","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.actbio.2022.12.057_bib0019","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1158\/1535-7163.MCT-18-0354","article-title":"Tumor priming by SMO inhibition enhances antibody delivery and efficacy in a pancreatic ductal adenocarcinoma model","volume":"18","author":"Wang","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.actbio.2022.12.057_bib0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00256482","article-title":"Magnetoliposomes: formation and structural characterization","volume":"15","author":"De Cuyper","year":"1988","journal-title":"Eur. Biophys. J."},{"issue":"32","key":"10.1016\/j.actbio.2022.12.057_bib0021","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.1021\/la3024716","article-title":"Ultra magnetic liposomes for MR imaging, targeting, and hyperthermia","volume":"28","author":"Bealle","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.actbio.2022.12.057_bib0022","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1021\/ja0516460","article-title":"Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging","volume":"127","author":"Martina","year":"2005","journal-title":"JACS"},{"key":"10.1016\/j.actbio.2022.12.057_bib0023","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1148\/radiol.2442060912","article-title":"Magnetic targeting of nanometric magnetic fluid loaded liposomes to specific brain intravascular areas: a dynamic imaging study in mice","volume":"244","author":"Riviere","year":"2007","journal-title":"Radiol"},{"key":"10.1016\/j.actbio.2022.12.057_bib0024","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/02652048.2017.1339738","article-title":"Thermo-responsive magnetic liposomes for hyperthermia-\u200btriggered local drug delivery","volume":"34","author":"Dai","year":"2017","journal-title":"J. Microencap."},{"key":"10.1016\/j.actbio.2022.12.057_bib0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1039\/C0JM01061H","article-title":"Size-controlled magnetoliposomes with tunable magnetic resonance relaxation enhancements","volume":"21","author":"Meledandri","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.actbio.2022.12.057_bib0026","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1021\/cm050060+","article-title":"Nonaqueous synthesis, characterization, and solubility","volume":"17","author":"Pinna","year":"2005","journal-title":"Chem. Mater."},{"key":"10.1016\/j.actbio.2022.12.057_bib0027","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.actbio.2022.12.057_bib0028","unstructured":"Pancreatic Cancer, About the Pancreas - Prognosis. (Accessed 12\/10 2020)."},{"key":"10.1016\/j.actbio.2022.12.057_bib0029","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.actbio.2022.12.057_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/proteomes6040045","article-title":"A comparative quantitative LC-MS\/MS profiling analysis of human pancreatic adenocarcinoma, adjacent-normal tissue, and patient-derived tumour xenografts","volume":"6","author":"Coleman","year":"2018","journal-title":"Proteomes"},{"key":"10.1016\/j.actbio.2022.12.057_bib0031","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amjsurg.2007.02.026","article-title":"Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas","volume":"195","author":"Muller","year":"2008","journal-title":"Am. J. Surg"},{"key":"10.1016\/j.actbio.2022.12.057_bib0032","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.actbio.2022.12.057_bib0033","article-title":"A phase 1\/2 study of metronomic 5-fluorouracil (5-FU) plus nabpaclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer","volume":"28","author":"Vincent","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.actbio.2022.12.057_bib0034","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/978-1-60761-416-6_21","article-title":"Circumventing tumor resistance to chemotherapy by nanotechnology","volume":"596","author":"Liang","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actbio.2022.12.057_bib0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1634\/theoncologist.2012-0435","article-title":"FOLFIRINOX in locally advanced pancreatic cancer: the massachusetts general hospital cancer center experience","volume":"18","author":"Faris","year":"2013","journal-title":"The Oncologist"},{"key":"10.1016\/j.actbio.2022.12.057_bib0036","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/jmri.24691","article-title":"Emerging applications for ferumoxytol as a contrast agent in MRI","volume":"41","author":"Bashir","year":"2015","journal-title":"J. Magn. Res. Imag."},{"key":"10.1016\/j.actbio.2022.12.057_bib0037","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.crad.2018.02.021","article-title":"Ferumoxytol-enhanced MRI in the peripheral vasculature","volume":"74","author":"Lehrman","year":"2019","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.actbio.2022.12.057_bib0038","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajh.21656","article-title":"Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease","volume":"85","author":"Lu","year":"2010","journal-title":"Am. J. Hema."},{"key":"10.1016\/j.actbio.2022.12.057_bib0039","doi-asserted-by":"crossref","unstructured":"Rienso: Application for New Indication Withdrawn, Reactions Weekly 1542 (2015).","DOI":"10.1007\/s40278-015-8414-x"},{"key":"10.1016\/j.actbio.2022.12.057_bib0040","doi-asserted-by":"crossref","first-page":"1802278","DOI":"10.1002\/smll.201802278","article-title":"Size-controlled nanoparticle assembly: size-controlled nanoparticle clusters of narrow size-polydispersity formed using multiple particle types through competitive stabilizer desorption to a liquid\u2013liquid interface","volume":"14","author":"Fox","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.actbio.2022.12.057_bib0041","series-title":"The Preparation and Characterisation of Stable Colloids of Magnetic Nanoparticles and Nanoparticle Assemblies with Controlled Size and Magnetic Properties, School of Chemistry","author":"Fox","year":"2013"},{"key":"10.1016\/j.actbio.2022.12.057_bib0042","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.bbamem.2012.05.007","article-title":"Molecular structures of fluid phase phosphatidylglycerol bilayers as determined by small angle neutron and X-ray scattering","volume":"1818","author":"Pan","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.actbio.2022.12.057_bib0043","article-title":"Field-cycling NMR relaxometry instrumentation, model theories and applications preface","volume":"18","author":"Kimmich","year":"2019","journal-title":"New Dev Nmr"},{"issue":"2","key":"10.1016\/j.actbio.2022.12.057_bib0044","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1039\/c2ay05420e","article-title":"Low field magnetic resonance techniques in the development of nanomaterials for biomedical applications","volume":"4","author":"Meledandri","year":"2012","journal-title":"Anal Methods-Uk"},{"key":"10.1016\/j.actbio.2022.12.057_bib0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/mrm.20058","article-title":"Inversion recovery trueFISP: quantification of T(1), T(2), and Spin density","volume":"51","author":"Schmitt","year":"2004","journal-title":"Magn. Res. in Med."},{"key":"10.1016\/j.actbio.2022.12.057_bib0046","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0005-2736(00)00224-8","article-title":"Novel inner monolayer fusion assays reveal differential monolayer mixing associated with cation-dependent membrane fusion","volume":"1467","author":"Meers","year":"2000","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.actbio.2022.12.057_bib0047","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1479-5876-3-22","article-title":"The anti-tumor effect of Apo2L\/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice","volume":"3","author":"Hylander","year":"2005","journal-title":"J. Trans. Med."},{"key":"10.1016\/j.actbio.2022.12.057_bib0048","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.actbio.2022.12.057_bib0049","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.actbio.2022.12.057_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115636","article-title":"Tumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo","volume":"10","author":"NDong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2022.12.057_bib0051","unstructured":"ISO, ISO 22412:2017 Particle size analysis \u2014 Dynamic light scattering (DLS), 2017."},{"key":"10.1016\/j.actbio.2022.12.057_bib0052","series-title":"Fundamentals for Molecular Spectroscopy","author":"Banwell","year":"1972"},{"issue":"5","key":"10.1016\/j.actbio.2022.12.057_bib0053","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/smll.200500006","article-title":"Synthesis, properties, and applications of iron nanoparticles","volume":"1","author":"Huber","year":"2005","journal-title":"Small"},{"key":"10.1016\/j.actbio.2022.12.057_bib0054","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jconrel.2020.05.046","article-title":"DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models","volume":"324","author":"Johnston","year":"2020","journal-title":"J. Cont. Rel."},{"key":"10.1016\/j.actbio.2022.12.057_bib0055","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.eurpolymj.2013.02.025","article-title":"Structural characterization of the poly(ethylene glycol) layer of sterically stabilized liposomes by means of FTIR spectroscopy","volume":"49","author":"Varga","year":"2013","journal-title":"Eur. Polym. J."},{"issue":"26","key":"10.1016\/j.actbio.2022.12.057_bib0056","doi-asserted-by":"crossref","first-page":"15053","DOI":"10.1039\/C9RA02529D","article-title":"Magnetoliposomes with size controllable insertion of magnetic nanoparticles for efficient targeting of cancer cells","volume":"9","author":"Choi","year":"2019","journal-title":"Rsc Adv"},{"key":"10.1016\/j.actbio.2022.12.057_bib0057","series-title":"NMR Studies of Membrane-Bound Nanoparticles and Nanoparticle Assemblies","author":"Meledandri","year":"2008"},{"issue":"30","key":"10.1016\/j.actbio.2022.12.057_bib0058","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1021\/ja0516460","article-title":"Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging","volume":"127","author":"Martina","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"1-2","key":"10.1016\/j.actbio.2022.12.057_bib0059","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2007.06.047","article-title":"Preparation and characterization of extruded magnetoliposomes","volume":"347","author":"Sabate","year":"2008","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.actbio.2022.12.057_bib0060","doi-asserted-by":"crossref","DOI":"10.1186\/2008-2231-22-44","article-title":"Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin","volume":"22","author":"Gharib","year":"2014","journal-title":"Daru"},{"issue":"2","key":"10.1016\/j.actbio.2022.12.057_bib0061","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1148\/radiol.2392042110","article-title":"Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility","volume":"239","author":"Fortin-Ripoche","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.actbio.2022.12.057_bib0062","doi-asserted-by":"crossref","first-page":"13337","DOI":"10.1039\/C6CC05871J","article-title":"Size selectable nanoparticle assemblies with magnetic anisotropy tunable across the superparamagnetic to ferromagnetic range","volume":"52","author":"Stolarczyk","year":"2016","journal-title":"Chem. Comm."},{"key":"10.1016\/j.actbio.2022.12.057_bib0063","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1021\/nn201348s","article-title":"Water-soluble superparamagnetic magnetite nanoparticles with biocompatible coating for enhanced magnetic resonance imaging","volume":"5","author":"Xiao","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2022.12.057_bib0064","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1063\/1.478435","article-title":"Theory of proton relaxation induced by superparamagnetic particles","volume":"110","author":"Roch","year":"1999","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.actbio.2022.12.057_bib0065","doi-asserted-by":"crossref","first-page":"14159","DOI":"10.1021\/la8018088","article-title":"Nonaqueous magnetic nanoparticle suspensions with controlled particle size and nuclear magnetic resonance properties","volume":"24","author":"Meledandri","year":"2008","journal-title":"Lang"},{"key":"10.1016\/j.actbio.2022.12.057_bib0066","first-page":"987","article-title":"Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes","volume":"54","author":"Gabizon","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2022.12.057_bib0067","doi-asserted-by":"crossref","first-page":"115101","DOI":"10.1088\/0957-4484\/22\/11\/115101","article-title":"The effects of particle size, density and shape on margination of nanoparticles in microcirculation","volume":"22","author":"Toy","year":"2011","journal-title":"Nanotech"},{"key":"10.1016\/j.actbio.2022.12.057_bib0068","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1078-0432.CCR-09-1913","article-title":"Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts","volume":"6","author":"Walter","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"36","key":"10.1016\/j.actbio.2022.12.057_bib0069","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.62.8719","article-title":"Randomized phase Ib\/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer","volume":"33","author":"Catenacci","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.actbio.2022.12.057_bib0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MPA.0000000000000458","article-title":"A phase i study of FOLFIRINOX Plus IPI-926, a Hedgehog pathway inhibitor, for advanced pancreatic adenocarcinoma","volume":"45","author":"Ko","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.actbio.2022.12.057_bib0071","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jmr.2012.11.029","article-title":"Magnetic particle imaging (MPI) for NMR and MRI researchers","volume":"229","author":"Saritas","year":"2013","journal-title":"J. Magn. Reson."},{"key":"10.1016\/j.actbio.2022.12.057_bib0072","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cbpa.2018.04.014","article-title":"Magnetic particle imaging for radiation-free, sensitive and high-contrast vascular imaging and cell tracking","volume":"45","author":"Zhou","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"23","key":"10.1016\/j.actbio.2022.12.057_bib0073","doi-asserted-by":"crossref","first-page":"11362","DOI":"10.1039\/c3nr03861k","article-title":"Tracking stem cells in tissue-engineered organs using magnetic nanoparticles","volume":"5","author":"Hachani","year":"2013","journal-title":"Nanoscale"},{"issue":"10","key":"10.1016\/j.actbio.2022.12.057_bib0074","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41416-020-01046-6","article-title":"Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer","volume":"123","author":"Greene","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.actbio.2022.12.057_bib0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1479-5876-11-110","article-title":"Origin of the vasculature supporting growth of primary patient tumor xenografts","volume":"11","author":"Hylander","year":"2013","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.actbio.2022.12.057_bib0076","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MPA.0000000000000099","article-title":"Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L\/TRAIL therapy","volume":"43","author":"Sharma","year":"2014","journal-title":"Pancreas"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122008698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122008698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:25:01Z","timestamp":1778624701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706122008698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":76,"alternative-id":["S1742706122008698"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2022.12.057","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2022.12.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}